Saturday, December 4, 2021
Home News Medical News

Medical News

A new study has shown the efficacy of AB569, a topical drug containing acidified nitrite and EDTA (ethylenediaminetetraacetic acid), in killing antibiotic-resistance bacteria. The drug was also found to promote wound healing in severe burns.
Gilead Sciences and Merck announced last week that they have paused a clinical trial of islatravir and lenacapavir for the treatment of HIV. The companies said they are doing so out of an abundance of caution. Islatravir and lenacapavir are investigational HIV drugs.
The Food and Drug Administration (FDA) has recently approved the use of Takeda’s Livtencity (maribavir) for patients ages 12 and above with post-transplant cytomegalovirus (CMV) infection. It is also approved for patients with CMV infection who are resistant to several other antiviral drugs.
A new Australian study has found that a small RNA molecule called microRNA-21 and suggested that inhibiting this molecule can help treat chronic obstructive pulmonary disease (COPD). Antagomir-21, a microRNA-21 inhibitor, was found effective for COPD in a mouse model.
The Food and Drug Administration has approved the use of Fyarro for the treatment of a rare and aggressive type of sarcoma called metastatic malignant perivascular epithelioid cell tumor. Fyarro, developed by Aadi Bioscience, contains sirolimus protein-bound particles, available in injectable suspension.
New research has found that insulin, a hormone that regulates blood glucose levels, decreased dopamine, the most important brain chemical that is associated with reward process, emotion, cognitive functions, and more.
Connecticut health officials have reported several cases of overdoses associated with marijuana, yet suffering from symptoms similar to opioid overdose. The state officials said at least one case has tested positive for marijuana laced with fentanyl.